RPCEC00000075
Not yet recruiting
Phase 2
Clinical evaluation of the effect anti-inflammatory of the extract of Mangifera indica L. (Vimang®) in patient with diagnosis of Bronchial Asthma.
Center of Pharmaceutical Chemistry0 sites88 target enrollmentMarch 13, 2009
ConditionsBronchial Asthma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Bronchial Asthma
- Sponsor
- Center of Pharmaceutical Chemistry
- Enrollment
- 88
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients of both sexes, between 20 and 45 years of age, non smokers, who are attended in ambulatory clinics, with diagnosis of persistent moderate asthma that they will be classified by the obstruction degree by spirometry according to Gina 2006\. \-Patient that are of agreement with participating in the clinical trial \-Patients have carried out a Respiratory Functional Test (RFT) with test pre and post bronchial dilator before beginning to take the Vimang® and that it expresses a limitation to the air, reversible or partially reversible flow with bronchial dilator(inhaled Salbutamol).
Exclusion Criteria
- •\- Smoking Patients. \- Pregnancy or nursing. \- Patients that have normal RFT. \- Patient without antecedents of bronchial asthma. \- The patient's negative to fulfill the established dose of the Vimang®. \- The patient's negative to carry out the protocolized investigations. \- Patient that not fulfill with the measures of systematic control: weekly phone calls that include the control of the asthma, besides the biweekly consultation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Comparative study of the effect of anti-inflammatory diet and barberry intake on non-alcoholic fatty liver status of childreIRCT20181111041611N6Kermanshah University of Medical Sciences48
Not yet recruiting
Not Applicable
Clinical Study to Evaluate the Anti-Inflammatory and Beneficial Effects ofBeta Glucan food supplement on Duchenne muscular dystrophy (DMD) PatientsCTRI/2022/05/042905MediNippon Health Care Private Limited MD
Not yet recruiting
Not Applicable
Clinical Study to Evaluate the Anti-Inflammatory and Beneficial Effects ofBeta Glucan foodsupplement on another Muscular Dystrophy other than DMD PatientsCTRI/2022/05/042917MediNippon Health Care Private Limited MD
Active, not recruiting
Phase 2
Efficacy of anti-inflammatory drugs in jaw-joint pain in edentulous patients.Temporo-mandibular joint painOther muscular or skeletal disordersMusculoskeletal - Other muscular and skeletal disordersACTRN12624000434594Srdjan D. Postic90
Completed
Not Applicable
Effect of ibuprofen + caffeine administration on the reduction of dental sensitivity from in-office bleachingRBR-48c9xtniversidade Estadual de Ponta Grossa - UEPG